Molecular probes for the human adenosine receptors

Adenosine receptors, G protein-coupled receptors (GPCRs) that are activated by the endogenous ligand adenosine, have been considered potential therapeutic targets in several disorders. To date however, only very few adenosine receptor modulators have made it to the market. Increased understanding of these receptors is required to improve the success rate of adenosine receptor drug discovery. To improve our understanding of receptor structure and function, over the past decades, a diverse array of molecular probes has been developed and applied. These probes, including radioactive or fluorescent moieties, have proven invaluable in GPCR research in general. Specifically for adenosine receptors, the development and application of covalent or reversible probes, whether radiolabeled or fluorescent, have been instrumental in the discovery of new chemical entities, the characterization and interrogation of adenosine receptor subtypes, and the study of adenosine receptor behavior in physiological and pathophysiological conditions. This review summarizes these applications, and also serves as an invitation to walk another mile to further improve probe characteristics and develop additional tags that allow the investigation of adenosine receptors and other GPCRs in even finer detail.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:17

Enthalten in:

Purinergic signalling - 17(2021), 1 vom: 14. März, Seite 85-108

Sprache:

Englisch

Beteiligte Personen:

Yang, Xue [VerfasserIn]
Heitman, Laura H [VerfasserIn]
IJzerman, Adriaan P [VerfasserIn]
van der Es, Daan [VerfasserIn]

Links:

Volltext

Themen:

8L70Q75FXE
Adenosine Triphosphate
Adenosine receptors
Chemical biology
Covalent ligands
Fluorescent Dyes
Fluorescent ligands
GPCR
Journal Article
Molecular Probes
PET ligands
Probes
Radioligands
Receptors, Purinergic P1
Research Support, Non-U.S. Gov't
Review

Anmerkungen:

Date Completed 09.12.2021

Date Revised 11.11.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1007/s11302-020-09753-8

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM318792737